Latest News

Amos Espinosa, a PhD candidate in the Krause Laboratory and a medical research scholar in the Yale Combined Program in the Biological and Biomedical Sciences, has been awarded an F31 NRSA Fellowship from the National Cancer Institute

Yale researchers present novel strategies for creating computer simulations and providing better emergency care, uncover new information about gut bacteria, and moderate a national discussion about science.

A team led by John Tsang, PhD, MMath, Anthony N. Brady Professor of Immunobiology, has been awarded a £4,200,000 grant from the Advanced Research + Invention Agency (ARIA) for a project that aims to decode and engineer coordinated immune responses that rapidly clear viruses in an effort to minimize viral spread and immunopathology.

Gut-homing antibodies provide powerful protection against norovirus, a new Yale study finds, revealing a potential new path for developing vaccines and therapies.

In a Q&A, Yale cancer scientist Luisa Escobar-Hoyos explains the challenges within pancreatic cancer treatment—and how patient outcomes can be improved.

Stem cells have reshaped modern biology. At Yale School of Medicine, researchers are uncovering how they function and how to harness them for human health.

Advances in single-cell, molecular, and genetic techniques drive biomedical innovation, and YSM researchers are expanding what’s possible.

Breaker, a field-leading biochemist and Yale leader, will serve as the FAS dean of science for a five-year term.

David Stitelman, MD, has received funding from the Cystic Fibrosis Research Institute to advance his collaborative research on a novel fetal therapy approach for cystic fibrosis. Working with colleagues across pediatric pulmonology, biomedical engineering, and gene editing, his team is developing nanoparticle-based strategies to deliver gene therapies before birth—aimed at preventing organ damage that begins in utero. By combining mRNA delivery and high-fidelity gene editing, this work has the potential to move toward a one-time treatment for cystic fibrosis and establish a new paradigm for treating genetic diseases before birth.